MENU
+Compare
WDNA
ETF ticker: BATS
AS OF
Aug 28, 04:51 PM (EDT)
Price
$14.14
Change
-$0.23 (-1.60%)
Net Assets
2.15M

WDNA stock forecast, quote, news & analysis

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”)... Show more

Category: #Health
WDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for WDNA with price predictions
Aug 27, 2025

WDNA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for WDNA turned positive on August 15, 2025. Looking at past instances where WDNA's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

WDNA moved above its 50-day moving average on August 13, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for WDNA crossed bullishly above the 50-day moving average on August 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for WDNA moved above the 200-day moving average on August 25, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WDNA advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for WDNA moved out of overbought territory on July 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where WDNA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on WDNA as a result. In of 64 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WDNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for WDNA entered a downward trend on August 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Pfizer (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Market Cap

The average market capitalization across the WisdomTree BioRevolution ETF ETF is 38.7B. The market cap for tickers in the group ranges from 64.65K to 659.82B. LLY holds the highest valuation in this group at 659.82B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the WisdomTree BioRevolution ETF ETF was 36%. For the same ETF, the average monthly price growth was 189%, and the average quarterly price growth was 163%. GPRE experienced the highest price growth at 31%, while GNS experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the WisdomTree BioRevolution ETF ETF was -5%. For the same stocks of the ETF, the average monthly volume growth was -28% and the average quarterly volume growth was -36%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 72
Price Growth Rating: 54
SMR Rating: 78
Profit Risk Rating: 84
Seasonality Score: -31 (-100 ... +100)
View a ticker or compare two or three
WDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
WisdomTree Trust380 Madison AveNew York
Phone
866-909-9473
Web
www.wisdomtree.com